BioCentury | Feb 26, 2021
Distillery Therapeutics

Blocking COL1 for multiple sclerosis

...Francisco, San Francisco, Calif.email: thomas.arnold@ucsf.eduCONTACT: Richard Daneman, University of California, San Diego, La Jolla, Calif.email: rdaneman@ucsd.edu Claire Quang University of California San Diego University...
BioCentury | Feb 23, 2021
Distillery Therapeutics

Mir690, NADK as targets in insulin resistance

...14, 2021doi:10.1016/j.cmet.2020.12.019CONTACT: Wei Ying, University of California San Diego, San Diego, Calif.email: weying@health.ucsd.eduCONTACT: Jerrold M. Olefsky, same affiliation as aboveemail: jolefsky@health.ucsd.edu Claire Quang University of California San Diego NAD...
BioCentury | Jan 30, 2021
Distillery Therapeutics

Epigenetic repressors of repetitive elements as cancer targets

...available for partneringPUBLICATION DETAILS: Shen, J. et al. Cell; published online Dec. 23, 2020doi:10.1016/j.cell.2020.11.042CONTACT: Jeremy N. Rich, University of California San Diego...
...Spruck, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, Calif.email: cspruck@sbpdiscovery.org Claire Quang Sanford Burnham Prebys Medical Discovery Institute University of California San Diego Suppressor...
BioCentury | Jan 23, 2021
Translation in Brief

Ionis’ ASO therapy for MM; plus epigenetic modification prevents myeloma-associated bone loss and bryostatin analogs reduce neuroinflammation

...G9A) – Euchromatic histone-lysine N-methyltransferase 2 IRF4 – Interferon regulatory factor 4PKC – Protein kinase C Danielle Golovin University of California San Diego Ionis...
BioCentury | Dec 18, 2020
Regulation

FDA panel for mRNA-1273 highlights challenges ahead for COVID vaccine trial recruitment, retention

...Sawyer, professor of clinical pediatrics at the University of California San Diego.Separately...
BioCentury | Dec 12, 2020
Regulation

As U.S. joins U.K., Canada in authorizing BNT162b2 for COVID-19, all eyes turn to deployment

...Sawyer, professor of clinical pediatrics at the University of California San Diego...
BioCentury | Dec 11, 2020
Product Development

Pfizer-BioNTech COVID-19 vaccine endorsed at shambolic advisory committee meeting

...Sawyer, professor of clinical pediatrics at the University of California San Diego...
BioCentury | Sep 19, 2020
Translation in Brief

Gene therapies from Passage Bio, Locanabio; Lava’s antitumor bispecific, health disparities in Alzheimer’s and more

...see “Passage Bio Outlines Clinical Goals”).Locanabio’s RNA-targeting gene therapyScientists at Locanabio Inc, with collaborators at University of California San Diego...
...– GranulinPGRN (PCDGF) - Progranulin TCR – T cell receptor Danielle Golovin PBFT02 Passage Bio Inc. University of Pennsylvania Locana Inc. University of California San Diego University...
BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...based on the work of co-founder Prashant Mali, an assistant professor of bioengineering at the University of California San Diego.Behind...
BioCentury | Jun 27, 2020
Tools & Techniques

Tapping astrocytes to replace lost neurons in Parkinson’s

...regenerative medicine approach that involves transforming one cell type in the body into another, a University of California San Diego...
...share many features with glial cells, a family of cells that incudes astrocytes, making the UCSD...
...analogous to the hearing loss approaches. In a study p ublished in Nature , the UCSD...
Items per page:
1 - 10 of 610
BioCentury | Feb 26, 2021
Distillery Therapeutics

Blocking COL1 for multiple sclerosis

...Francisco, San Francisco, Calif.email: thomas.arnold@ucsf.eduCONTACT: Richard Daneman, University of California, San Diego, La Jolla, Calif.email: rdaneman@ucsd.edu Claire Quang University of California San Diego University...
BioCentury | Feb 23, 2021
Distillery Therapeutics

Mir690, NADK as targets in insulin resistance

...14, 2021doi:10.1016/j.cmet.2020.12.019CONTACT: Wei Ying, University of California San Diego, San Diego, Calif.email: weying@health.ucsd.eduCONTACT: Jerrold M. Olefsky, same affiliation as aboveemail: jolefsky@health.ucsd.edu Claire Quang University of California San Diego NAD...
BioCentury | Jan 30, 2021
Distillery Therapeutics

Epigenetic repressors of repetitive elements as cancer targets

...available for partneringPUBLICATION DETAILS: Shen, J. et al. Cell; published online Dec. 23, 2020doi:10.1016/j.cell.2020.11.042CONTACT: Jeremy N. Rich, University of California San Diego...
...Spruck, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, Calif.email: cspruck@sbpdiscovery.org Claire Quang Sanford Burnham Prebys Medical Discovery Institute University of California San Diego Suppressor...
BioCentury | Jan 23, 2021
Translation in Brief

Ionis’ ASO therapy for MM; plus epigenetic modification prevents myeloma-associated bone loss and bryostatin analogs reduce neuroinflammation

...G9A) – Euchromatic histone-lysine N-methyltransferase 2 IRF4 – Interferon regulatory factor 4PKC – Protein kinase C Danielle Golovin University of California San Diego Ionis...
BioCentury | Dec 18, 2020
Regulation

FDA panel for mRNA-1273 highlights challenges ahead for COVID vaccine trial recruitment, retention

...Sawyer, professor of clinical pediatrics at the University of California San Diego.Separately...
BioCentury | Dec 12, 2020
Regulation

As U.S. joins U.K., Canada in authorizing BNT162b2 for COVID-19, all eyes turn to deployment

...Sawyer, professor of clinical pediatrics at the University of California San Diego...
BioCentury | Dec 11, 2020
Product Development

Pfizer-BioNTech COVID-19 vaccine endorsed at shambolic advisory committee meeting

...Sawyer, professor of clinical pediatrics at the University of California San Diego...
BioCentury | Sep 19, 2020
Translation in Brief

Gene therapies from Passage Bio, Locanabio; Lava’s antitumor bispecific, health disparities in Alzheimer’s and more

...see “Passage Bio Outlines Clinical Goals”).Locanabio’s RNA-targeting gene therapyScientists at Locanabio Inc, with collaborators at University of California San Diego...
...– GranulinPGRN (PCDGF) - Progranulin TCR – T cell receptor Danielle Golovin PBFT02 Passage Bio Inc. University of Pennsylvania Locana Inc. University of California San Diego University...
BioCentury | Sep 10, 2020
Finance

Korro Bio’s $91.5M series A brings in new investors, launches hunt for CEO

...based on the work of co-founder Prashant Mali, an assistant professor of bioengineering at the University of California San Diego.Behind...
BioCentury | Jun 27, 2020
Tools & Techniques

Tapping astrocytes to replace lost neurons in Parkinson’s

...regenerative medicine approach that involves transforming one cell type in the body into another, a University of California San Diego...
...share many features with glial cells, a family of cells that incudes astrocytes, making the UCSD...
...analogous to the hearing loss approaches. In a study p ublished in Nature , the UCSD...
Items per page:
1 - 10 of 610